TheraRadar
Company Portfolios →

Vertex Pharmaceuticals Incorporated

29 active trials across 9 therapeutic areas

29
Active Trials
9
Phase 1
9
Phase 2
16
Phase 3
9
Therapeutic Areas

Respiratory

10 active / 78 total
Cystic Fibrosis
10 active 5 Ph3
78 total since 2015

Immunology

9 active / 13 total
Ankylosing Spondylitis
6 active 5 Ph3
10 total since 2015
Rheumatoid Arthritis
3 active 3 Ph3
3 total since 2015

Cardiovascular

6 active / 9 total
Myocardial Infarction
6 active 4 Ph3
9 total since 2015

Pain

5 active / 39 total
Neuropathic Pain
4 active 3 Ph3
4 total since 2015
Acute Pain
1 active
35 total since 2015

Rare Disease

3 active / 5 total
Sickle Cell Disease
3 active 3 Ph3
5 total since 2015

Oncology

3 active / 4 total
Neuroendocrine Tumors
3 active 3 Ph3
4 total since 2015

Metabolic

3 active / 3 total
Type 1 Diabetes
3 active 2 Ph3
3 total since 2015

CNS

0 active / 2 total
Neuropathy
0 active
2 total since 2015

Musculoskeletal

0 active / 1 total
Osteoarthritis
0 active
1 total since 2015

Click an indication to see competitive landscape (all sponsors in that indication).

Data: ClinicalTrials.gov (2015+)